www.israel21c.org/headlines/using-parasites-to-fight-autoimmune-diseases/" Shoenfeld and his team set out to mimic the helminth secretions that suppress a host’s immune system. The compound they patented, called TCP, is the basis of a startup they have established. They are seeking investors or pharmaceutical companies to mass produce the compound.
TCP is a mixture of two existing molecules in the body – phosphorylcholine, a non-immunogenic substance, and tuftsin, which is produced in the spleen and helps suppress the immune system. When introduced to mice in the lab at the center, via injection and orally, TCP completely eradicated lupus, colitis and rheumatoid arthritis."